Read More

Senseonics And Ascensia Announce A Collaboration With The Nurse Practitioner Group Designed To Expand Patient Access By Providing In-office And At-home Insertion Options For Eversense E3 Continuous Glucose Monitoring System

Senseonics Holdings, Inc. (NYSE:SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, and Ascensia

SENS